✦ LIBER ✦

Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients

✍ Scribed by Ke-Da Yu; Guang-Yu Liu; Gen-Hong Di; Jiong Wu; Jin-Song Lu; Kun-Wei Shen; Zhen-Zhou Shen; Zhi-Ming Shao

Book ID: 113506857
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 230 KB
Volume: 16
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2006.12.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of progesterone re

Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen

✍ Yong Wha Moon; Seho Park; Joo Hyuk Sohn; Dae Ryong Kang; Ja Seung Koo; Hyung Seo 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 235 KB

Adjuvant therapy for breast cancer with

Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status

✍ Saul E. Rivkin; William A. Knight; Robert McDivitt; Tony Cruz; Mary Foulkes; C. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 430 KB

Adjuvant therapy for breast cancer with

Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status

✍ Saul E. Rivkin; William A. Knight III; Robert McDivitt; Tony Cruz; Mary Foulkes; 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 463 KB

Estrogen and progesterone receptors in t

Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

✍ Andrea Manni; Baha'Uddin Arafah; Olof H. Pearson 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to

Breast density change as a predictive su

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

✍ Jisun Kim, Wonshik Han, Hyeong-Gon Moon, Soo Kyung Ahn, Hee-Chul Shin, Jee-Man Y 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 198 KB

Activated HER-receptors in predicting ou

Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy

✍ Mathilde S. Larsen; Karsten Bjerre; Anne E. Lykkesfeldt; Anita Giobbie-Hurder; A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 382 KB